Northern Trust’s Dogwood Therapeutics DWTX Stock Holding History

Northern Trust’s Portfolio DWTX Stock Details DWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.3K	Hold	23,779	–	–	﹤0.01%	4304
2026 Q1	$50.2K	Buy	+23,779	New	+$70K	﹤0.01%	4243
2024 Q4	–	Sell	-961	Closed	-$4.09K	–	4497
2024 Q3	$4.09K	Hold	961	–	–	﹤0.01%	4404
2024 Q2	$5.17K	Hold	961	–	–	﹤0.01%	4403
2024 Q1	$11.5K	Hold	961	–	–	﹤0.01%	4379
2023 Q4	$13.8K	Hold	961	–	–	﹤0.01%	4397
2023 Q3	$22.2K	Hold	961	–	–	﹤0.01%	4314
2023 Q2	$33.2K	Buy	961 +328	+52%	+$9.36K	﹤0.01%	4309
2023 Q1	$5.82K	Hold	633	–	–	﹤0.01%	4559
2022 Q4	$3.74K	Hold	633	–	–	﹤0.01%	4635
2022 Q3	$6K	Hold	633	–	–	﹤0.01%	4672
2022 Q2	$67K	Buy	633 +28	+5%	+$2.93K	﹤0.01%	4322
2022 Q1	$68K	Hold	605	–	–	﹤0.01%	4457
2021 Q4	$77K	Buy	+605	New	+$77K	﹤0.01%	4498

Other funds holding DWTX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust's DWTX Position: Q2 2026 in Review

Northern Trust held its Dogwood Therapeutics (DWTX) position steady in Q2 2026 at 23,779 shares worth $38.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4304.

Northern Trust first reported a position in DWTX in Q4 2021 and has held it in 14 quarters since. The position peaked at $77K in Q4 2021. 15 funds tracked by Wall St. Rank hold DWTX as of Q2 2026.

Northern Trust held 23,779 shares of Dogwood Therapeutics worth $38.3K as of Q2 2026.
Northern Trust left its Dogwood Therapeutics share count unchanged in Q2 2026.
Dogwood Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4304 holding.
Northern Trust first reported a position in Dogwood Therapeutics in Q4 2021 and has held it in 14 quarters since.
Northern Trust's Dogwood Therapeutics position peaked at $77K in Q4 2021.
15 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.